Wesley Pharmaceuticals
FDA 503B outsourcing facility
Orlando, Florida
Key Takeaways
- FDA-registered 503B outsourcing facility since 2025
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: March 16, 2026
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- July 25, 2025
- Most recent registration
- November 22, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- March 16, 2026
- NPI
- 1609767417
The FDA last inspected Wesley Pharmaceuticals on March 16, 2026. No Form FDA 483 was issued at that inspection. The FDA has not yet determined whether further action will be taken.
What this facility compounds
Wesley Pharmaceuticals reports compounding 1 distinct active ingredient to the FDA Outsourcing Facility Product Report (most recent reporting periods).
- Zinc Sulfate Heptahydrate
Location
5551 VANGUARD ST, Orlando, FL
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Mark Mikhael, 1-407-440-1555. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Wesley Pharmaceuticals with the Florida Board of Pharmacy.
503B facilities in Florida
Florida has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Florida.
Frequently asked questions
Is Wesley Pharmaceuticals registered with the FDA?
Yes. Wesley Pharmaceuticals is a registered 503B outsourcing facility, first registered with the FDA on July 25, 2025 and most recently registered on November 22, 2025.
Has Wesley Pharmaceuticals been inspected by the FDA?
The FDA last inspected Wesley Pharmaceuticals on March 16, 2026. No Form 483 was issued.
Has Wesley Pharmaceuticals had any FDA drug recalls?
No FDA drug recalls are matched to Wesley Pharmaceuticals in the openFDA enforcement database.
What does Wesley Pharmaceuticals compound?
Wesley Pharmaceuticals reports compounding 1 active ingredient to the FDA.
Where is Wesley Pharmaceuticals located?
Wesley Pharmaceuticals is located in Orlando, Florida (5551 VANGUARD ST).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Wesley Pharmaceuticals. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.